{"id":"https://openalex.org/W1991250346","doi":"https://doi.org/10.1158/0008-5472.can-12-3109","title":"Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity","display_name":"Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity","alternate_titles":[],"publication_year":2013,"publication_date":"2013-03-14","ids":{"openalex":"https://openalex.org/W1991250346","doi":"https://doi.org/10.1158/0008-5472.can-12-3109","mag":"1991250346","pmid":"https://pubmed.ncbi.nlm.nih.gov/23333938"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-12-3109","doi":"https://doi.org/10.1158/0008-5472.can-12-3109","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-12-3109","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1991250346"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113871544","display_name":"Charity L. Atkins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Charity Atkins","raw_affiliation_strings":["Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101757038","display_name":"Qi Liu","orcid":"https://orcid.org/0000-0002-6113-856X","observed_orcids":["https://orcid.org/0000-0002-6113-856X"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Qi Liu","raw_affiliation_strings":["Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026299053","display_name":"Elisabeth A. Minthorn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elisabeth Minthorn","raw_affiliation_strings":["Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017523981","display_name":"ShuYun Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shu-Yun Zhang","raw_affiliation_strings":["Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063142060","display_name":"David J. Figueroa","orcid":"https://orcid.org/0009-0009-6442-0104","observed_orcids":["https://orcid.org/0009-0009-6442-0104"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David J. Figueroa","raw_affiliation_strings":["Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027900173","display_name":"Katherine G. Moss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Katherine Moss","raw_affiliation_strings":["Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062942262","display_name":"Thomas B. Stanley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas B. Stanley","raw_affiliation_strings":["Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109209782","display_name":"Brent M. Sanders","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Brent Sanders","raw_affiliation_strings":["Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038559618","display_name":"Aaron S. Goetz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aaron Goetz","raw_affiliation_strings":["Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081165425","display_name":"Nathan Gaul","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nathan Gaul","raw_affiliation_strings":["Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078450169","display_name":"Anthony E. Choudhry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anthony E. Choudhry","raw_affiliation_strings":["Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078359962","display_name":"Hasan Alsaid","orcid":"https://orcid.org/0000-0001-6600-2146","observed_orcids":["https://orcid.org/0000-0001-6600-2146"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hasan Alsaid","raw_affiliation_strings":["Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009295868","display_name":"Beat M. Jucker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Beat M. Jucker","raw_affiliation_strings":["Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031552626","display_name":"Jeffrey M. Axten","orcid":"https://orcid.org/0000-0002-8999-3381","observed_orcids":["https://orcid.org/0000-0002-8999-3381"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeffrey M. Axten","raw_affiliation_strings":["Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075000175","display_name":"Rakesh Kumar","orcid":"https://orcid.org/0000-0002-6384-1160","observed_orcids":["https://orcid.org/0000-0002-6384-1160","https://orcid.org/0009-0009-7852-7631"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rakesh Kumar","raw_affiliation_strings":["Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081GlaxoSmithKline, Oncology R&D; 2Platform Technology & Science, Collegeville, Pennsylvania; 3Platform Technology & Science, Research Triangle Park, North Carolina; and 4Preclinical and Translational Imaging, LAS, King of Prussia, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210114143"],"apc_list":null,"apc_paid":null,"fwci":11.3638,"has_fulltext":false,"cited_by_count":487,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.99514749,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"73","issue":"6","first_page":"1993","last_page":"2002"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11150","display_name":"Endoplasmic Reticulum Stress and Disease","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11150","display_name":"Endoplasmic Reticulum Stress and Disease","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gsk2656157","display_name":"GSK2656157","score":0.9810000061988831},{"id":"https://openalex.org/keywords/unfolded-protein-response","display_name":"unfolded protein response","score":0.9610000252723694},{"id":"https://openalex.org/keywords/perk","display_name":"PERK","score":0.9079999923706055},{"id":"https://openalex.org/keywords/eif2alpha-phosphorylation","display_name":"eIF2\u03b1 phosphorylation","score":0.8730000257492065},{"id":"https://openalex.org/keywords/atf4","display_name":"ATF4","score":0.9169999957084656},{"id":"https://openalex.org/keywords/chop","display_name":"CHOP","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8199999928474426},{"id":"https://openalex.org/keywords/antiangiogenic-activity","display_name":"antiangiogenic activity","score":0.9860000014305115},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.8769999742507935},{"id":"https://openalex.org/keywords/pancreatic-function","display_name":"pancreatic function","score":0.6039999723434448},{"id":"https://openalex.org/keywords/amino-acid-metabolism","display_name":"amino acid metabolism","score":0.7799999713897705},{"id":"https://openalex.org/keywords/blood-vessel-density","display_name":"blood vessel density","score":0.7620000243186951},{"id":"https://openalex.org/keywords/vascular-perfusion","display_name":"vascular perfusion","score":0.734000027179718},{"id":"https://openalex.org/keywords/kinase-inhibitor-selectivity","display_name":"kinase selectivity","score":0.8650000095367432}],"concepts":[{"id":"https://openalex.org/C150109051","wikidata":"https://www.wikidata.org/wiki/Q3630494","display_name":"Autophosphorylation","level":4,"score":0.6184732913970947},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5683287978172302},{"id":"https://openalex.org/C139447449","wikidata":"https://www.wikidata.org/wiki/Q14633900","display_name":"Unfolded protein response","level":3,"score":0.5520756244659424},{"id":"https://openalex.org/C2780900454","wikidata":"https://www.wikidata.org/wiki/Q21102119","display_name":"ATF4","level":4,"score":0.5219178199768066},{"id":"https://openalex.org/C2779638656","wikidata":"https://www.wikidata.org/wiki/Q6043166","display_name":"Integrated stress response","level":5,"score":0.5183592438697815},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4739777445793152},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.43274545669555664},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42004960775375366},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36939528584480286},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.3622581362724304},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35417038202285767},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3264341354370117},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.30657511949539185},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20725670456886292},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.14181005954742432},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.0},{"id":"https://openalex.org/C149364088","wikidata":"https://www.wikidata.org/wiki/Q185917","display_name":"Translation (biology)","level":4,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019892","descriptor_name":"eIF-2 Kinase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/0008-5472.can-12-3109","doi":"https://doi.org/10.1158/0008-5472.can-12-3109","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-12-3109","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:23333938","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23333938","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W1507019195","https://openalex.org/W1530012584","https://openalex.org/W1682474579","https://openalex.org/W1763493018","https://openalex.org/W1964050579","https://openalex.org/W1965893213","https://openalex.org/W1968503605","https://openalex.org/W1973454536","https://openalex.org/W1978390469","https://openalex.org/W1983738559","https://openalex.org/W1996826558","https://openalex.org/W2015780669","https://openalex.org/W2016000163","https://openalex.org/W2053442171","https://openalex.org/W2066815702","https://openalex.org/W2068055557","https://openalex.org/W2068335749","https://openalex.org/W2070993901","https://openalex.org/W2072754204","https://openalex.org/W2075266492","https://openalex.org/W2079791855","https://openalex.org/W2097731764","https://openalex.org/W2098786698","https://openalex.org/W2106958893","https://openalex.org/W2108252761","https://openalex.org/W2111334976","https://openalex.org/W2114079476","https://openalex.org/W2119902047","https://openalex.org/W2120736516","https://openalex.org/W2125262828","https://openalex.org/W2126530235","https://openalex.org/W2127906377","https://openalex.org/W2128327076","https://openalex.org/W2137368432","https://openalex.org/W2152354289","https://openalex.org/W2154372386","https://openalex.org/W2157926318","https://openalex.org/W2161371655","https://openalex.org/W2163285372","https://openalex.org/W2163470744","https://openalex.org/W2167661346","https://openalex.org/W2168735820","https://openalex.org/W2171233023","https://openalex.org/W4205324621"],"related_works":["https://openalex.org/W2054854053","https://openalex.org/W2080034938","https://openalex.org/W2503009163","https://openalex.org/W4409690730","https://openalex.org/W2072286499","https://openalex.org/W2804197381","https://openalex.org/W4296663008","https://openalex.org/W2057079958","https://openalex.org/W4362541497","https://openalex.org/W4230971628"],"abstract_inverted_index":{"The":[0],"unfolded":[1],"protein":[2,142,144],"response":[3,162],"(UPR)":[4],"is":[5,43,76,91],"a":[6,51,102,157],"signal":[7],"transduction":[8],"pathway":[9],"that":[10,17],"coordinates":[11],"cellular":[12],"adaptation":[13],"to":[14,154,232],"microenvironmental":[15],"stresses":[16],"include":[18],"hypoxia,":[19],"nutrient":[20],"deprivation,":[21],"and":[22,35,139,159,195],"change":[23],"in":[24,32,111,116,137,146,163,176,185,227,236],"redox":[25],"status.":[26],"These":[27],"stress":[28],"stimuli":[29],"are":[30,198],"common":[31],"many":[33],"tumors":[34],"thus":[36],"targeting":[37],"components":[38],"of":[39,56,68,72,80,87,104,119,126,152,173,179,216,223],"the":[40,57,69,117,202,212],"UPR":[41,73],"signaling":[42],"an":[44,77,85,114],"attractive":[45],"therapeutic":[46],"approach.":[47],"We":[48],"have":[49],"identified":[50],"first-in-class,":[52],"small":[53],"molecule":[54],"inhibitor":[55,79,226],"eukaryotic":[58],"initiation":[59],"factor":[60],"2-alpha":[61],"kinase":[62],"3":[63],"(EIF2AK3)":[64],"or":[65],"PERK,":[66],"one":[67],"three":[70],"mediators":[71],"signaling.":[74],"GSK2656157":[75,107,153,174],"ATP-competitive":[78],"PERK":[81,95,109,128,168,217,225],"enzyme":[82],"activity":[83,110],"with":[84,96,113,134],"IC(50)":[86,97,115],"0.9":[88],"nmol/L.":[89],"It":[90],"highly":[92],"selective":[93],"for":[94,201],"values":[98],">100":[99],"nmol/L":[100,121],"against":[101],"panel":[103],"300":[105],"kinases.":[106],"inhibits":[108],"cells":[112],"range":[118],"10-30":[120],"as":[122,165],"shown":[123],"by":[124,167],"inhibition":[125,178,218],"stress-induced":[127],"autophosphorylation,":[129],"eIF2\u03b1":[130],"substrate":[131],"phosphorylation,":[132],"together":[133],"corresponding":[135],"decreases":[136],"ATF4":[138],"CAAT/enhancer":[140],"binding":[141],"homologous":[143],"(CHOP)":[145],"multiple":[147,180],"cell":[148],"lines.":[149],"Oral":[150],"administration":[151],"mice":[155],"shows":[156],"dose-":[158],"time-dependent":[160],"pharmacodynamic":[161],"pancreas":[164],"measured":[166],"autophosphorylation.":[169],"Twice":[170],"daily":[171],"dosing":[172],"results":[175],"dose-dependent":[177],"human":[181,228],"tumor":[182],"xenografts":[183],"growth":[184],"mice.":[186],"Altered":[187],"amino":[188],"acid":[189],"metabolism,":[190],"decreased":[191],"blood":[192],"vessel":[193],"density,":[194],"vascular":[196],"perfusion":[197],"potential":[199],"mechanisms":[200],"observed":[203],"antitumor":[204,209],"effect.":[205],"However,":[206],"despite":[207],"its":[208],"activity,":[210],"given":[211],"on-target":[213],"pharmacologic":[214],"effects":[215],"on":[219],"pancreatic":[220],"function,":[221],"development":[222],"any":[224],"subjects":[229],"would":[230],"need":[231],"be":[233],"cautiously":[234],"pursued":[235],"cancer":[237],"patients.":[238]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1991250346","counts_by_year":[{"year":2026,"cited_by_count":19},{"year":2025,"cited_by_count":28},{"year":2024,"cited_by_count":29},{"year":2023,"cited_by_count":32},{"year":2022,"cited_by_count":39},{"year":2021,"cited_by_count":39},{"year":2020,"cited_by_count":49},{"year":2019,"cited_by_count":46},{"year":2018,"cited_by_count":44},{"year":2017,"cited_by_count":37},{"year":2016,"cited_by_count":32},{"year":2015,"cited_by_count":42},{"year":2014,"cited_by_count":35},{"year":2013,"cited_by_count":15}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
